Methylphenidate and Belviq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylphenidate (methylphenidate) and Belviq (lorcaserin hydrochloride). Common drug interactions include anaphylactic reaction among females.

The phase IV clinical study analyzes what interactions people have when they take Methylphenidate and Belviq. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.

What is Belviq?

Belviq has active ingredients of lorcaserin hydrochloride. It is often used in weight loss. eHealthMe is studying from 3,179 Belviq users. Check the latest studies of Belviq.

On Jul, 26, 2026

14 people who take Methylphenidate and Belviq together, and have interactions are studied.

Methylphenidate and Belviq drug interactions.

What are the common drug interactions of Methylphenidate and Belviq, by gender? *:

female:

Anaphylactic reaction (serious allergic reaction)
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Blood pressure decreased
Depression
Muscle spasms (muscle contraction)
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)
White blood cell count decreased
Constipation
Drug ineffective

male:

n/a

What are the common drug interactions of Methylphenidate and Belviq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Constipation
Gait disturbance
Memory impairment
Sedation
Speech disorder

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)

50-59:

Chronic kidney disease
Depression
Muscle spasms (muscle contraction)
Renal failure (kidney dysfunction)
Hospitalisation
Surgery

60+:

Anaphylactic reaction (serious allergic reaction)
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 78.57%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 21.43%
Stress And Anxiety: 2 people, 14.29%
Hypersensitivity: 2 people, 14.29%
Neuralgia (pain in one or more nerves): 2 people, 14.29%
Depression: 2 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Gastric Ulcer (stomach ulcer): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate and Belviq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously